Instrument Fundamentals
Date | Close | Change | Change (%) | Open | High | Low |
---|
News

Cellectis SA (CLLS) Q4 2024 Earnings Call Highlights: Strategic Collaborations and Financial ...

AstraZeneca (AZN) Highlights Promising Trial Results for Enhertu in Breast Cancer Treatment | ...

Sustainability and AI in healthcare

AstraZeneca (NASDAQ:AZN) Shares Acquired Rep. Bruce Westerman

Capital International Inc. CA Raises Holdings in AstraZeneca PLC (NASDAQ:AZN)

Capital International Investors Buys 686,008 Shares of AstraZeneca PLC (NASDAQ:AZN)

AstraZeneca PLC (NASDAQ:AZN) Sees Significant Decline in Short Interest

Mariner LLC Acquires 25,998 Shares of AstraZeneca PLC (NASDAQ:AZN)

Federal parties release costed platforms with less than two weeks to election day | Watch News Videos Online

BI Asset Management Fondsmaeglerselskab A S Makes New $58.82 Million Investment in AstraZeneca PLC (NASDAQ:AZN)

Insigneo Advisory Services LLC Reduces Stake in AstraZeneca PLC (NASDAQ:AZN)

Mariner LLC Buys 25,998 Shares of AstraZeneca PLC (NASDAQ:AZN)

Dodge & Cox Sells 5,325 Shares of AstraZeneca PLC (NASDAQ:AZN)

Guggenheim Capital LLC Sells 7,836 Shares of AstraZeneca PLC (NASDAQ:AZN)

Bank of Nova Scotia Buys Shares of 4,761 AstraZeneca PLC (NASDAQ:AZN)

Antibody-drug Conjugates Innovations Research Report 2025: $227 Billion in Deals Signal ADC Market Boom - Pfizer and Daiichi Sankyo Emerge as Leading Trial Sponsors | Valuespectrum.com

AstraZeneca Subsidiary Accused of Soliris Drug Market Monopoly

BNP Paribas Begins Coverage on AstraZeneca (NASDAQ:AZN)

Bruce Murray's Top Picks: Meta, Eli Lilly & Linamar - BNN Bloomberg

AstraZeneca unit faces class-action suit over alleged Soliris monopoly
Six FTSE 100 stock ideas for the second quarter, according to Barclays
This industrial giant is the UK's largest business, but it's not a FTSE 100 stock!

EU pharma sector explains duty fears - World - Chinadaily.com.cn

AstraZeneca PLC (NASDAQ:AZN) Shares Purchased by Causeway Capital Management LLC
The top 3 mistakes to avoid if the stock market crashes

AstraZeneca PLC (LON:AZN) Receives Consensus Recommendation of "Moderate Buy" from Analysts

CUHK joins hands with AstraZeneca to boost research into clinical practice | The Standard

Is AstraZeneca PLC (AZN) the Best Pharma Stock to Buy for Long Term Growth?

AstraZeneca (NASDAQ:AZN) Now Covered by Analysts at BNP Paribas

Sanders Capital LLC Has $995.03 Million Position in AstraZeneca PLC (NASDAQ:AZN)

Bridgewater Associates LP Has $44.13 Million Position in AstraZeneca PLC (NASDAQ:AZN)

Kennedy Capital Management LLC Buys 35,977 Shares of AstraZeneca PLC (NASDAQ:AZN)

Q4 EPS Estimates for AstraZeneca Lowered by Zacks Research
A market rally could be coming for UK stocks: here's what I'm buying

Asthma control and opportunities to optimize management and the healthcare provider experience using the AsthmaOptimiser online tool in Dutch general practice: the CAPTURE study

Circulating tumour DNA and circulating tumour cells in bladder cancer - from discovery to clinical implementation

AstraZeneca PLC (LSE:AZN) in Artisan International Fund Q3 2024

F M Investments LLC Has $1.45 Million Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)

Bessemer Group Inc. Sells 4,115 Shares of AstraZeneca PLC (NASDAQ:AZN)

Invesco Ltd. Lowers Stock Position in AstraZeneca PLC (NASDAQ:AZN)

AstraZeneca PLC (NASDAQ:AZN) Shares Sold by Legal & General Group Plc

Norges Bank Acquires Shares of 16,378 AstraZeneca PLC (NASDAQ:AZN)

How we treat mantle cell lymphoma with cellular therapy in 2025: the European and American perspectives

Bronchodilators Market Grows with Rising Prevalence of Asthma and COPD Cases - Express Press Release Distribution

Act Two Investors LLC Lowers Holdings in AstraZeneca PLC (NASDAQ:AZN)

Zacks Research Decreases Earnings Estimates for AstraZeneca

Scotia Capital Inc. Sells 181,745 Shares of AstraZeneca PLC (NASDAQ:AZN)

DRW Securities LLC Lowers Stake in AstraZeneca PLC (NASDAQ:AZN)

Advisory Services Network LLC Has $1.28 Million Stock Position in AstraZeneca PLC (NASDAQ:AZN)

First Foundation Advisors Trims Position in AstraZeneca PLC (NASDAQ:AZN)

AstraZeneca PLC (NASDAQ:AZN) Shares Purchased by Phoenix Financial Ltd.

AstraZeneca (NASDAQ:AZN) Shares Gap Down - Here's Why

AstraZeneca Chairman Says Drug Tariffs Would Harm Patients

Dymon Asia Capital Singapore PTE. LTD. Invests $1.05 Million in AstraZeneca PLC (NASDAQ:AZN)

AstraZeneca (LON:AZN) Reaches New 52-Week Low - What's Next?

Serum sphingomyelin levels define oxyhemoglobin desaturation-related metabolic threshold in symptomatic obstructive sleep apnea

Error-corrected flow-based sequencing at whole-genome scale and its application to circulating cell-free DNA profiling

AstraZeneca fends off diabetes generic, for now

Health Canada approves IMFINZI® (durvalumab) as the first and only immunotherapy regimen for adult patients with limited-stage small cell lung cancer (LS-SCLC)
Clive Palmer-supported vaccine injury case 'incoherent', 'unintelligible' and 'ambiguous'

AstraZeneca Settles Covid-Shot Suit With Christian Salesman

AstraZeneca PLC (AZN) Shares Gap Down to $62 on Apr 9

AstraZeneca (AZN) Faces Challenges Amid Potential Tariffs

RHHBY, LLY, AZN Face Market Pressure Due to New Tariff Concerns

AstraZeneca (AZN): A Long-Term Growth Opportunity Under $70

Fmr LLC Sells 805,930 Shares of AstraZeneca PLC (NASDAQ:AZN)

Peapack Gladstone Financial Corp Sells 47,590 Shares of AstraZeneca PLC (NASDAQ:AZN)
Trending tickers: Apple, Advanced Micro Devices, Ford, BP and AstraZeneca

AstraZeneca's Camizestrant Shows Promise in SERENA-6 Breast Cancer Trial

AstraZeneca (AZN) Gains EU Nod for Imfinzi Combo in NSCLC Treatment

AstraZeneca (AZN) Gains EU Approval for Expanded Enhertu Use in Breast Cancer

AstraZeneca (AZN) Gains Momentum with EU Drug Approvals

AstraZeneca (AZN) Prepares for Upcoming Earnings Amid Stock Decline

Solrikitug Emerges as a Promising Anti-TSLP Therapy for Severe Asthma, Poised to Address Critical Unmet Needs | DelveInsight | ABNewswire

Modified pegRNAs mitigate scaffold-derived prime editing by-products

Autologous T cell therapy for PRAME + advanced solid tumors in HLA-A*02 + patients: a phase 1 trial

Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia - long-term follow-up with focus on younger patients

AstraZeneca PLC (AZN) Stock Price Down 5.81% on Apr 7

Arete Wealth Advisors LLC Grows Holdings in AstraZeneca PLC (NASDAQ:AZN)

AstraZeneca PLC (NASDAQ:AZN) Receives Average Recommendation of "Buy" from Brokerages

China, America and pay inject drama into AstraZeneca's AGM

Pitcairn Co. Cuts Stake in AstraZeneca PLC (NASDAQ:AZN)
Just opened a Stocks and Shares ISA? Here are 10 stocks to consider buying, according to AI

AstraZeneca (NASDAQ:AZN) Shares Gap Up - What's Next?

Cinctive Capital Management LP Grows Stock Position in AstraZeneca PLC (NASDAQ:AZN)

AstraZeneca (LON:AZN) Stock Price Passes Above 200-Day Moving Average - Time to Sell?

AstraZeneca PLC (AZN) Shares Down 6.67% on Apr 4

Daiichi Sankyo (4568) and AstraZeneca Receive EU Approval for Enhertu in Breast Cancer Treatment

Case: Patents/Antitrust (D. Del.)

AstraZeneca PLC (NASDAQ:AZN) Shares Sold by Nomura Asset Management Co. Ltd.

AstraZeneca And Daiichi Sankyo's Enhertu Approved In EU For Advanced Breast Cancer Treatment

Policy Fallout Continues; Rise in Lung Cancer Screening; Going Public With Denials

Precision Omics Initiative Sweden (PROMISE) will integrate research with healthcare
AstraZeneca PLC (LON:AZN) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

AIM ImmunoTech Inc. (AMEX:AIM) Q4 2024 Earnings Call Transcript

Glofitamab in refractory or relapsed diffuse large B cell lymphoma after failing CAR-T cell therapy: a phase 2 LYSA study

AstraZeneca CEO: China already a global innovation hub | govt.chinadaily.com.cn
Latest news

Stock Market Today: Dow, S&P 500, Nasdaq Fall as Trump Rips Fed Chair Powell

Morning Note: Trump's Fed Pressure Slams Stocks, Boosts Gold; Oil Recovers

Gold Price Today: XAU/USD Over $3,350 on Trump's Tariff Policies Uncertainty

Morning Note: Dollar Falls on Trump-Fed Fears; Japan in US Trade Talks; China holds rates